Expression of WSX1 in tumors sensitizes IL-27 signaling-independent natural killer cell surveillance
about
Interleukin-27: balancing protective and pathological immunityWSX1 expression in tumors induces immune tolerance via suppression of effector immune cells.Safety and efficacy of tumor-targeted interleukin 12 gene therapy in treated and non-treated, metastatic lesions.Immune checkpoint regulator PD-L1 expression on tumor cells by contacting CD11b positive bone marrow derived stromal cells.Modulation of inflammation by interleukin-27.Antimelanoma immunotherapy: clinical and preclinical applications of IL-12 family members.Mutant p53 in concert with an interleukin-27 receptor alpha deficiency causes spontaneous liver inflammation, fibrosis, and steatosis in miceDual Roles of IL-27 in Cancer Biology and Immunotherapy.Regulation and Immune Function of IL-27.IL27 controls skin tumorigenesis via accumulation of ETAR-positive CD11b cells in the pre-malignant skinLack of Immunomodulatory Interleukin-27 Enhances Oncogenic Properties of Mutant p53 In Vivo.Coordination between TLR9 signaling in macrophages and CD3 signaling in T cells induces robust expression of IL-30.The cross talk between cervical carcinoma cells and vascular endothelial cells mediated by IL-27 restrains angiogenesis.IL-27 - a double agent in the IL-6 family.
P2860
Q26830400-89D95584-88D6-4101-98A6-B63D79A7175BQ33895262-15AAD74E-045F-42D0-BB56-0F5141AEEEF0Q34791427-B7E20FE9-3E44-4E42-B266-A0254E924B9FQ35159355-96A8FAD2-3B84-460D-A592-378CF4584DA4Q37309924-FD35A3DD-430A-481D-B998-A13E88EF8C82Q37793235-7CFFE986-626D-4516-B552-A834F3578B22Q38603775-D6518C5A-90E7-4C3B-82BF-A8E0B34162FEQ39158943-3B150FBC-97BB-4A06-9ADA-39CFC34899EEQ40508641-125FC11E-2868-49AC-9776-018ED88A07E7Q42056219-538066D9-AA01-4026-809C-91C88243E80AQ42144816-25E8E0BF-C6EE-4A92-AB4C-4E1F63B7C604Q42170091-049B79CA-9379-447C-AB39-582EAD31F3EBQ48139778-1B060476-F371-441F-BCE7-58B832A8A38CQ50045633-FC8E4ABE-A799-4388-B46F-68E476915961
P2860
Expression of WSX1 in tumors sensitizes IL-27 signaling-independent natural killer cell surveillance
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Expression of WSX1 in tumors s ...... tural killer cell surveillance
@en
Expression of WSX1 in tumors s ...... ural killer cell surveillance.
@nl
type
label
Expression of WSX1 in tumors s ...... tural killer cell surveillance
@en
Expression of WSX1 in tumors s ...... ural killer cell surveillance.
@nl
prefLabel
Expression of WSX1 in tumors s ...... tural killer cell surveillance
@en
Expression of WSX1 in tumors s ...... ural killer cell surveillance.
@nl
P2093
P2860
P1433
P1476
Expression of WSX1 in tumors s ...... tural killer cell surveillance
@en
P2093
Denada Dibra
Jeffry J Cutrera
Mark P Birkenbach
Xueqing Xia
P2860
P304
P356
10.1158/0008-5472.CAN-08-4311
P407
P577
2009-06-23T00:00:00Z